IL143003A0 - Pharmaceutical composition for modified release insulin sensitiser - Google Patents

Pharmaceutical composition for modified release insulin sensitiser

Info

Publication number: IL143003A0
Authority: IL; Israel
Prior art keywords: pharmaceutical composition; modified release; release insulin; insulin sensitiser; sensitiser
Prior art date: 1998-11-12

Application number

IL14300399A

Other languages

English (en)

Original Assignee

Smithkline Beecham Corp

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-12

Filing date

1999-11-12

Publication date

2002-04-21

1998-11-12 Priority claimed from GBGB9824870.1A external-priority patent/GB9824870D0/en

1999-05-25 Priority claimed from GBGB9912189.9A external-priority patent/GB9912189D0/en

1999-11-12 Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp

2002-04-21 Publication of IL143003A0 publication Critical patent/IL143003A0/xx

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
231100000489 sensitizer Toxicity 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Thiazole And Isothizaole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL14300399A 1998-11-12 1999-11-12 Pharmaceutical composition for modified release insulin sensitiser IL143003A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9824870.1A GB9824870D0 (en)	1998-11-12	1998-11-12	Novel composition and use
GBGB9912189.9A GB9912189D0 (en)	1999-05-25	1999-05-25	Novel composition and use
PCT/EP1999/009031 WO2000028990A1 (fr)	1998-11-12	1999-11-12	Composition pharmaceutique de sensibilisateur modifiant la liberation d'insuline

Publications (1)

Publication Number	Publication Date
IL143003A0 true IL143003A0 (en)	2002-04-21

Family

ID=26314667

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14300399A IL143003A0 (en)	1998-11-12	1999-11-12	Pharmaceutical composition for modified release insulin sensitiser
IL183972A IL183972A0 (en)	1998-11-12	2007-06-14	Pharmaceutical composition for modified release insulin sensitiser

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL183972A IL183972A0 (en)	1998-11-12	2007-06-14	Pharmaceutical composition for modified release insulin sensitiser

Country Status (39)

Country	Link
EP (3)	EP1128827B1 (fr)
JP (1)	JP2002529505A (fr)
KR (2)	KR20060097140A (fr)
CN (1)	CN1289081C (fr)
AP (2)	AP2008004490A0 (fr)
AR (2)	AR023700A1 (fr)
AT (1)	ATE382352T1 (fr)
AU (1)	AU768578B2 (fr)
BG (2)	BG65444B1 (fr)
BR (1)	BR9915215A (fr)
CA (1)	CA2350659C (fr)
CO (1)	CO5190673A1 (fr)
CY (1)	CY1107909T1 (fr)
CZ (1)	CZ20011628A3 (fr)
DE (1)	DE69937898T2 (fr)
DK (1)	DK1128827T3 (fr)
DZ (1)	DZ2937A1 (fr)
EA (3)	EA200702648A1 (fr)
EG (2)	EG22344A (fr)
ES (1)	ES2299269T3 (fr)
HK (1)	HK1040909B (fr)
HR (2)	HRP20010342B1 (fr)
HU (1)	HUP0104307A3 (fr)
ID (1)	ID29344A (fr)
IL (2)	IL143003A0 (fr)
MY (1)	MY135973A (fr)
NO (1)	NO20012351L (fr)
NZ (2)	NZ511611A (fr)
OA (1)	OA11676A (fr)
PE (1)	PE20001428A1 (fr)
PL (1)	PL198717B1 (fr)
PT (1)	PT1128827E (fr)
RS (1)	RS50208B (fr)
SI (1)	SI1128827T1 (fr)
SK (1)	SK286937B6 (fr)
TR (2)	TR200503846T2 (fr)
TW (2)	TWI257305B (fr)
UY (2)	UY25798A1 (fr)
WO (1)	WO2000028990A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6099862A (en) *	1998-08-31	2000-08-08	Andrx Corporation	Oral dosage form for the controlled release of a biguanide and sulfonylurea
MY125516A (en)	1999-11-16	2006-08-30	Smithkline Beecham Plc	Novel composition based on thiazolidinedione and metformin and use
CA2396237A1 (fr) *	2000-01-07	2001-07-19	Jacob Gabriel Michael	Activation selective d'une reponse immunitaire regulee par un lymphocyte th1 ou th2
JP5502254B2 (ja) *	2001-01-31	2014-05-28	エボニックレームゲゼルシャフトミットベシュレンクテルハフツング	少なくとも２種類の異なる被覆ペレット形から成る多粒子剤形
ES2259736T3 (es) *	2001-12-21	2006-10-16	Smithkline Beecham Corporation	Regimen de dosificacion para activadores de ppar-gamma-.
MY139719A (en) *	2002-02-12	2009-10-30	Glaxo Group Ltd	Oral dosage form for controlled drug release
AU2003281181A1 (en) *	2002-07-11	2004-02-02	Takeda Pharmaceutical Company Limited	Process for producing coated preparation
US7018658B2 (en) *	2002-11-14	2006-03-28	Synthon Bv	Pharmaceutical pellets comprising tamsulosin
ES2645930T3 (es) *	2003-01-03	2017-12-11	Supernus Pharmaceuticals, Inc.	Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas
WO2004067001A1 (fr)	2003-01-29	2004-08-12	Takeda Pharmaceutical Company Limited	Procede pour realiser une preparation enrobee
ES2241478B1 (es) *	2004-02-13	2006-11-16	Lacer S.A.	Preparacion farmaceutica para la liberacion sostenida de un principio farmaceuticamente activo.
FI20060501A7 (fi) *	2006-05-22	2007-11-23	Biohit Oyj	Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa
CA2878866C (fr) *	2011-07-14	2021-02-23	Able Cerebral, Llc	Composition, dispositif et procede pour la liberation retardee et prolongee de molecules energeniques pour le cerveau
CA3018328A1 (fr)	2014-10-31	2016-04-30	Purdue Pharma	Methodes et compositions destinees au traitement du trouble de deficit d'attention
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5522636A (en)	1978-08-04	1980-02-18	Takeda Chem Ind Ltd	Thiazoliding derivative
JPS5697277A (en)	1980-01-07	1981-08-05	Takeda Chem Ind Ltd	Thiazolidine derivative
JPS6051189A (ja)	1983-08-30	1985-03-22	Sankyo Co Ltd	チアゾリジン誘導体およびその製造法
US4582839A (en)	1984-03-21	1986-04-15	Takeda Chemical Industries, Ltd.	2,4-thiazolidinediones
CN1003445B (zh)	1984-10-03	1989-03-01	武田药品工业株式会社	噻唑烷二酮衍生物，其制备方法和用途
DK173350B1 (da)	1985-02-26	2000-08-07	Sankyo Co	Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja)	1985-06-10	1994-01-05	武田薬品工業株式会社	チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en)	1986-07-24	1989-03-14	Takeda Chemical Industries, Ltd.	Method for producing thiazolidinedione derivatives
ATE186724T1 (de)	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
US4791125A (en)	1987-12-02	1988-12-13	Pfizer Inc.	Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (fr)	1988-03-08	1989-09-21	Pfizer Inc.	Derives de thiaxolidinedione hypoglycemiques
FI904414A7 (fi)	1988-03-08	1990-09-07	Pfizer	Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet
WO1991007107A1 (fr)	1989-11-13	1991-05-30	Pfizer Inc.	Agents d'oxazolidinedione hypoglycemiques
US5089514A (en)	1990-06-14	1992-02-18	Pfizer Inc.	3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
AU650465B2 (en)	1990-07-03	1994-06-23	Yamanouchi Pharmaceutical Co., Ltd.	Bisheterocyclic compound
FI930772L (fi)	1990-08-23	1993-02-22	Pfizer	Hydroxiureaderivat som saenker glugosnivao i blodet
JPH04210683A (ja)	1990-12-06	1992-07-31	Terumo Corp	チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
KR100249988B1 (ko)	1991-04-11	2000-04-01	로렌스 티. 마이젠헬더	티아졸리딘디온 유도체, 그의 제조방법 및 용도
US5183823A (en)	1991-04-11	1993-02-02	Takeda Chemical Industries, Ltd.	Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
US5502078A (en) *	1991-05-28	1996-03-26	Zeneca Limited	Chemical compounds
TW222626B (fr)	1991-07-22	1994-04-21	Pfizer
FR2680512B1 (fr)	1991-08-20	1995-01-20	Adir	Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH05271204A (ja)	1992-03-26	1993-10-19	Japan Tobacco Inc	新規なトリアジン誘導体
US5264451A (en)	1992-04-07	1993-11-23	American Home Products Corporation	Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
AU3959193A (en)	1992-04-10	1993-11-18	Smithkline Beecham Plc	Heterocyclic compounds and their use in the treatment of type II-diabetes
WO1993022445A1 (fr)	1992-05-05	1993-11-11	The Upjohn Company	Procede de production de metabolites de pioglitazone
SK695A3 (en)	1992-07-03	1995-07-11	Smithkline Beecham Plc	Heterocyclic compounds method of their production and using
US5326770A (en) *	1992-07-17	1994-07-05	The Du Pont Merck Pharmaceutical Company	Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals
US5232945A (en)	1992-07-20	1993-08-03	Pfizer Inc.	3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
US5457109A (en) *	1993-09-15	1995-10-10	Warner-Lambert Company	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
DE4432757A1 (de) *	1994-09-14	1996-03-21	Boehringer Mannheim Gmbh	Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
TW438587B (en) *	1995-06-20	2001-06-07	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
US5840332A (en) *	1996-01-18	1998-11-24	Perio Products Ltd.	Gastrointestinal drug delivery system
JP3256841B2 (ja) *	1996-06-27	2002-02-18	武田薬品工業株式会社	ベンズアルデヒド化合物の製造法
US5952509A (en) *	1996-06-27	1999-09-14	Takeda Chemical Industries, Ltd.	Production of benzaldehyde compounds
GB9619757D0 (en) *	1996-09-21	1996-11-06	Knoll Ag	Chemical process
IL132032A0 (en) *	1997-03-24	2001-03-19	Galderma Res & Dev	Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus

1999
- 1999-11-10 DZ DZ990237A patent/DZ2937A1/fr active
- 1999-11-10 AR ARP990105699A patent/AR023700A1/es unknown
- 1999-11-10 AR ARP990105698A patent/AR023699A1/es unknown
- 1999-11-11 MY MYPI99004894A patent/MY135973A/en unknown
- 1999-11-11 EG EG142899A patent/EG22344A/xx active
- 1999-11-11 CO CO99070989A patent/CO5190673A1/es not_active Application Discontinuation
- 1999-11-11 EG EG142999A patent/EG24463A/xx active
- 1999-11-12 TR TR2005/03846T patent/TR200503846T2/xx unknown
- 1999-11-12 NZ NZ511611A patent/NZ511611A/en not_active IP Right Cessation
- 1999-11-12 EP EP99956029A patent/EP1128827B1/fr not_active Expired - Lifetime
- 1999-11-12 CN CNB998154946A patent/CN1289081C/zh not_active Expired - Fee Related
- 1999-11-12 PL PL348153A patent/PL198717B1/pl not_active IP Right Cessation
- 1999-11-12 NZ NZ526440A patent/NZ526440A/en not_active IP Right Cessation
- 1999-11-12 CA CA002350659A patent/CA2350659C/fr not_active Expired - Fee Related
- 1999-11-12 EP EP07105991A patent/EP1815855A1/fr not_active Withdrawn
- 1999-11-12 SK SK643-2001A patent/SK286937B6/sk not_active IP Right Cessation
- 1999-11-12 PT PT99956029T patent/PT1128827E/pt unknown
- 1999-11-12 ES ES99956029T patent/ES2299269T3/es not_active Expired - Lifetime
- 1999-11-12 HR HR20010342A patent/HRP20010342B1/xx not_active IP Right Cessation
- 1999-11-12 AP AP2008004490A patent/AP2008004490A0/xx unknown
- 1999-11-12 AT AT99956029T patent/ATE382352T1/de not_active IP Right Cessation
- 1999-11-12 BR BR9915215-0A patent/BR9915215A/pt not_active Application Discontinuation
- 1999-11-12 OA OA1200100116A patent/OA11676A/en unknown
- 1999-11-12 UY UY25798A patent/UY25798A1/es not_active Application Discontinuation
- 1999-11-12 ID IDW00200101047A patent/ID29344A/id unknown
- 1999-11-12 EA EA200702648A patent/EA200702648A1/ru unknown
- 1999-11-12 TR TR2001/01337T patent/TR200101337T2/xx unknown
- 1999-11-12 AU AU12729/00A patent/AU768578B2/en not_active Ceased
- 1999-11-12 HR HR20080117A patent/HRP20080117A2/xx not_active Application Discontinuation
- 1999-11-12 SI SI9931001T patent/SI1128827T1/sl unknown
- 1999-11-12 KR KR1020067017464A patent/KR20060097140A/ko not_active Ceased
- 1999-11-12 EA EA200100540A patent/EA007608B1/ru not_active IP Right Cessation
- 1999-11-12 WO PCT/EP1999/009031 patent/WO2000028990A1/fr not_active Ceased
- 1999-11-12 DK DK99956029T patent/DK1128827T3/da active
- 1999-11-12 EP EP07150269A patent/EP1917962A1/fr not_active Withdrawn
- 1999-11-12 RS YU36401A patent/RS50208B/sr unknown
- 1999-11-12 IL IL14300399A patent/IL143003A0/xx unknown
- 1999-11-12 EA EA200601144A patent/EA200601144A1/ru unknown
- 1999-11-12 DE DE69937898T patent/DE69937898T2/de not_active Expired - Lifetime
- 1999-11-12 JP JP2000582037A patent/JP2002529505A/ja active Pending
- 1999-11-12 AP APAP/P/2001/002135A patent/AP1901A/en active
- 1999-11-12 HK HK02101021.9A patent/HK1040909B/en not_active IP Right Cessation
- 1999-11-12 CZ CZ20011628A patent/CZ20011628A3/cs unknown
- 1999-11-12 HU HU0104307A patent/HUP0104307A3/hu unknown
- 1999-11-12 PE PE1999001147A patent/PE20001428A1/es not_active Application Discontinuation
- 1999-11-12 KR KR1020017005949A patent/KR100732599B1/ko not_active Expired - Fee Related
- 1999-11-15 UY UY25800A patent/UY25800A1/es not_active Application Discontinuation
- 1999-12-24 TW TW093132308A patent/TWI257305B/zh active
- 1999-12-24 TW TW088122852A patent/TWI246920B/zh not_active IP Right Cessation
2001
- 2001-05-11 NO NO20012351A patent/NO20012351L/no not_active Application Discontinuation
- 2001-06-07 BG BG105570A patent/BG65444B1/bg unknown
- 2001-06-07 BG BG109893A patent/BG109893A/bg unknown
2007
- 2007-06-14 IL IL183972A patent/IL183972A0/en unknown
2008
- 2008-03-19 CY CY20081100310T patent/CY1107909T1/el unknown

Also Published As

Publication number	Publication date
RS50208B (sr)	2009-07-15
AU768578B2 (en)	2003-12-18
ATE382352T1 (de)	2008-01-15
EP1917962A1 (fr)	2008-05-07
KR20060097140A (ko)	2006-09-13
AU1272900A (en)	2000-06-05
NO20012351D0 (no)	2001-05-11
DZ2937A1 (fr)	2004-03-15
EA200100540A1 (ru)	2001-10-22
KR100732599B1 (ko)	2007-06-27
CA2350659C (fr)	2009-06-09
UY25798A1 (es)	2000-12-29
AP2008004490A0 (en)	2008-06-30
WO2000028990A1 (fr)	2000-05-25
SK286937B6 (sk)	2009-07-06
JP2002529505A (ja)	2002-09-10
CN1333683A (zh)	2002-01-30
AP1901A (en)	2008-10-24
CA2350659A1 (fr)	2000-05-25
NZ526440A (en)	2005-01-28
HRP20080117A2 (en)	2008-10-31
EP1128827B1 (fr)	2008-01-02
NO20012351L (no)	2001-07-04
BR9915215A (pt)	2001-07-31
CO5190673A1 (es)	2002-08-29
PL348153A1 (en)	2002-05-06
SK6432001A3 (en)	2001-12-03
SI1128827T1 (sl)	2008-06-30
EG22344A (en)	2002-12-31
TW200505436A (en)	2005-02-16
EP1128827A1 (fr)	2001-09-05
HK1040909B (en)	2008-08-01
AR023699A1 (es)	2002-09-04
ID29344A (id)	2001-08-23
TR200101337T2 (tr)	2001-11-21
DE69937898D1 (de)	2008-02-14
HUP0104307A3 (en)	2003-12-29
DK1128827T3 (da)	2008-04-28
BG105570A (en)	2002-02-28
CN1289081C (zh)	2006-12-13
EA007608B1 (ru)	2006-12-29
PE20001428A1 (es)	2001-02-08
IL183972A0 (en)	2007-10-31
TR200503846T2 (tr)	2007-01-22
TWI257305B (en)	2006-07-01
EP1815855A1 (fr)	2007-08-08
OA11676A (en)	2005-01-12
KR20010073229A (ko)	2001-07-31
EG24463A (en)	2009-07-16
HRP20010342A2 (en)	2002-06-30
TWI246920B (en)	2006-01-11
ES2299269T3 (es)	2008-05-16
DE69937898T2 (de)	2009-01-02
AR023700A1 (es)	2002-09-04
MY135973A (en)	2008-07-31
BG65444B1 (bg)	2008-08-29
HK1040909A1 (en)	2002-06-28
PT1128827E (pt)	2008-03-10
HUP0104307A2 (hu)	2002-07-29
YU36401A (sh)	2004-05-12
CZ20011628A3 (cs)	2001-12-12
NZ511611A (en)	2003-10-31
EA200601144A1 (ru)	2007-02-27
EA200702648A1 (ru)	2008-10-30
CY1107909T1 (el)	2013-09-04
HRP20010342B1 (en)	2008-04-30
PL198717B1 (pl)	2008-07-31
UY25800A1 (es)	2000-08-21
BG109893A (bg)	2008-11-28

Publication	Publication Date	Title
IL183972A0 (en)	2007-10-31	Pharmaceutical composition for modified release insulin sensitiser
PT1131070E (pt)	2008-11-19	Composição farmacêutica para libertação modificada de um sensibilizador à insulina e de outro agente antidiabético
PL351387A1 (en)	2003-04-07	Pharmaceutical composition
IL145581A0 (en)	2002-11-10	A modified release pharmaceutical composition comprising amoxycillin
IL137105A0 (en)	2001-06-14	Method for administering aspb28-human insulin
HUP0104255A3 (en)	2002-12-28	An pharmaceutical composition suitable for inhalation
HUP0004024A3 (en)	2001-10-29	Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP0204109A3 (en)	2004-06-28	Oral preparations for diabetes
PT1466615E (pt)	2009-09-07	Composição farmacêutica
HUP0000137A3 (en)	2001-03-28	Controller-release pharmaceutical composition containing anangetics
PL343769A1 (en)	2001-09-10	Pharmaceutical composition
GB2347742B (en)	2001-11-07	Pharmaceutical composition for RBD
GB9818591D0 (en)	1998-10-21	Pharmaceutical composition
PL344834A1 (en)	2001-11-19	Pharmaceutical levothyroxine preparation
HUP0102842A3 (en)	2003-12-29	Pharmaceutical composition for injection based on paracetamol
HUP0202652A3 (en)	2004-06-28	Pharmaceutical carrier composition
PL354295A1 (en)	2004-01-12	Pharmaceutical composition comprising an insulin sensitizer
HUP0004132A3 (en)	2006-06-28	Rapidly soluble drug composition
HU9902296D0 (en)	1999-10-28	Pharmaceutical composition for treating caltification
GB9700855D0 (en)	1997-03-05	Pharmaceutical composition
HU9800078D0 (en)	1998-04-28	Pharmaceutical composition
IL145127A0 (en)	2002-06-30	Pharmaceutical composition based on polyaromatic compounds
HUP0101012A3 (en)	2002-12-28	Pharmaceutical composition for oral administration
GB9910671D0 (en)	1999-07-07	Improved pharmaceutical composition
GB9916210D0 (en)	1999-09-15	Pharmaceutical composition